使用Melody瓣膜经导管肺动脉瓣置换治疗功能失调的外科生物瓣:一项多中心研究
这项回顾性多中心研究纳入10个中心2010年1月至2015年6月间100例因外科肺动脉生物瓣功能失调行Melody经导管肺动脉瓣置换的患者,中位年龄22岁。出院时除1例外肺动脉反流均为轻度或更轻,右心室流出道平均跨瓣压差由29.3±12.0 mm Hg降至16.2±6.9 mm Hg(P<.001)。随访中位12.4个月期间无患者再次干预,仅1例诊断感染性心内膜炎并接受药物治疗。
要点
- Melody经导管肺动脉瓣置换可恢复功能失调外科肺动脉生物瓣的闭合性并解除梗阻。
- 出院时右心室流出道平均压差由29.3±12.0 mm Hg降至16.2±6.9 mm Hg(P<.001)。
- 随访中位12.4个月无再次干预,小瓣膜(≤23 mm)与大瓣膜(≥25 mm)血流动力学结局无差异。
核心结论
- 经导管肺动脉瓣置换可恢复功能失调外科生物瓣的闭合性并解除梗阻,在小瓣膜和大瓣膜中早期结果均良好,凸显其延长现有生物瓣寿命的潜力。
- 作者认为外科医生与心脏科医生的协作对于确定该人群联合外科肺动脉瓣置换与经导管肺动脉瓣置换的最佳终身管理很重要。
研究设计与样本
- 回顾性多中心研究,纳入10个中心2010年1月至2015年6月间接受Melody经导管肺动脉瓣置换进入功能失调肺动脉生物瓣的100例患者。
- 患者中位年龄22岁(范围5-79岁),其中32例年龄<18岁。
- 基础诊断为法洛四联症80例,中度或重度肺动脉反流占84%。
- 经导管肺动脉瓣植入各类生物瓣,中位尺寸23 mm(范围19-33 mm)。
主要发现
- 出院时除1例外肺动脉反流均为轻度或更轻。
- 右心室流出道平均多普勒压差由29.3±12.0 mm Hg降至16.2±6.9 mm Hg(中位29 mm Hg降至16 mm Hg;P<.001)。
- 随访中位12.4个月期间无患者对经导管肺动脉瓣行再次干预,1例诊断感染性心内膜炎并接受药物治疗未干预。
- 最近一次随访时所有患者右心室流出道平均压差≤35 mm Hg,与植入后早期相似,仅1例肺动脉反流超过轻度。
- 小生物瓣(≤23 mm)与大生物瓣(≥25 mm)患者血流动力学结局无差异。
临床怎么用
- 原文结论指出经导管肺动脉瓣置换在小瓣膜和大瓣膜中早期结果均良好,并强调外科医生与心脏科医生协作以确定该人群的最佳终身管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stented bioprosthetic valves (BPVs) are commonly used for surgical pulmonary valve (PV) replacement in postoperative congenital heart disease, but develop structural failure in a time-related fashion. The Melody transcatheter PV (TPV) (Medtronic, Minneapolis, Minn) has been used to treat BPV dysfunction, but there have been few studies in this population. METHODS: We performed a retrospective, multicenter study to evaluate Melody valve function in patients who underwent TPV replacement (TPVR) into a dysfunctional pulmonary BPV. RESULTS: One hundred patients who underwent TPVR at 10 centers between January 2010 and June 2015 were enrolled. The median patient age was 22 years (range, 5-79 years), and 32 patients were age <18 years. The underlying diagnosis was tetralogy of Fallot in 80 patients, and moderate or severe pulmonary regurgitation (PR) was present in 84%. The TPV was implanted into various types of BPVs, with a median size of 23 mm (range, 19-33 mm). At hospital discharge, PR was mild or less in all but 1 patient, and the mean Doppler right ventricular outflow tract (RVOT) gradient was reduced from a mean of 29.3 ± 12.0 mm Hg to 16.2 ± 6.9 mm Hg (median, 29 mm Hg to 16 mm Hg; P < .001). During follow-up (median, 12.4 months), no patients underwent reintervention on the TPV. Endocarditis was diagnosed in 1 patient who was managed medically without intervention. The mean RVOT gradient at the most recent follow-up was ≤35 mm Hg in all patients, and was similar to that at early postimplantation. PR was more than mild in only 1 patient. Hemodynamic outcomes did not differ between patients with small BPVs (≤23 mm) and those with large BPVs (≥25 mm). CONCLUSIONS: TPVR restores competence and relieves the obstruction of dysfunctional surgical BPVs, with excellent early results in both small and large BPVs, highlighting the potential for TPVR to extend the life of existing BPVs in adults and children. Collaboration between surgeons and cardiologists is important to determine the optimal lifetime management, combining surgical PV replacement and TPVR in this population.
引用
- Cabalka AK, Asnes JD, Balzer DT, et al. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study. J Thorac Cardiovasc Surg. 2017. PMID: 29395214. doi:10.1016/j.jtcvs.2017.10.143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。